SUMMARY A sensitive method for detecting rubella IgM antibody, the first step of which is the attachment of the serum IgM to a solid phase, is described.
Specific IgM antibody was found in all 52 people with acquired rubella in the early convalescent period, in all 38 infants with congenital rubella examined in the first seven months of life, and in 23 of 26 people immunised one to four months before testing. Twenty-four of 44 rheumatoid factor-positive sera, however, gave false-positive readings. In routine use the test was economical of both reagents and time.
Detection of rubella IgM antibody is well established as a means of diagnosing recent infection in pregnant women or congenital infection in neonates. Most methods rely on a primary step to separate physically the IgM from the other serum immunoglobulins, for example, sucrose gradient centrifugation or gel filtration.' Unfortunately, such methods of separating immunoglobulins lead to some loss, thus reducing the sensitivity of the test. More recently, radioimmunoassay and enzyme linked immunosorbant assay (ELISA) tests in which rubella antigen is bound to a solid phase have been used,2 but when whole serum is added to a solid phase antigen, competition between antibodies of the various classes may cause false-negative results.
In 1979 Duermeyer et a13 described a technique, the antibody capture assay, in which human IgM is selectively attached to the solid phase by anti-human IgM (anti-u chain) antibody. When antigen is then added it will bind to any of its antibody present in the IgM fraction of the serum being tested. Finally, the presence of the bound antigen is detected by antibody, labelled with an enzyme or radioisotope.
We report here the antibody capture assay using an enzyme linked indicator system for detecting rubella IgM antibody.
Material and methods

TEST SERA
Eighty-three sera were tested from 52 cases of clinical rubella, confirmed in the laboratory by seroconversion or a greater than fourfold rise in antibody titre. Thirty-five sera were tested from 28 infants Accepted for publication 13 May 1981 with congenital rubella, defined as a child having one or more defects associated with the syndrome4 and from whom the virus had been isolated or whose antibody persisted for more than 10 months from birth. Sera from 27 previously rubella seronegative women who had been recently immunised and sera from 260 women attending the antenatal clinic who had not been exposed to rubella, and who denied any recent rash or illness, were examined. To investigate the effect of rheumatoid factor (RF) on the test, 44 RF-positive sera were also tested.
PREPARATION OF THE ENZYME CONJUGATE
The periodate method for conjugating immunoglobulin and horseradish peroxidase was based on that of Nakane and Kawaoi (1974) .5 The immunoglobulin was prepared from the serum of a rabbit immunised with rubella virus grown in RK 13 cells. The serum was fractionated on a QAE-Sephadex A-50 column, 10 cm x 1 cm (Pharmacia Ltd), with 0.1 M ethylene diamine-acetic acid buffer pH 7-0.
The protein concentration of the immunoglobulin was adjusted to 4 mg/ml and it was then dialysed overnight against 0-01 M sodium carbonate buffer pH 9 5.
Horseradish peroxidase (4 mg) (Sigma Chemical Co) was dissolved in 1 ml distilled water and 0-2 ml freshly prepared 0-1 M sodium periodate added. This mixture was stirred for 20 min and then dialysed overnight against 1 mM sodium acetate buffer pH 4*4. The pH of the mixture was raised to 9-5 with 0-2 ml of 0-2 M sodium carbonate buffer pH 9-5. One ml of the immunoglobulin preparation was added and stirred for two hours at room temperature, then 0-1 ml of a solution of sodium borohydride (4 mg/ml distilled water) was added to 1392 break down any remaining free enzyme. After standing for two hours at +4°C the conjugate was dialysed overnight against 0-1 M borate buffer pH 7-4 and then diluted with an equal volume of 60 % glycerol in borate buffer. It was stored at + 4°C.
PREPARATION OF THE SOLID PHASE
The wells of polystyrene micro-ELISA plates (Dynatech Laboratories) were coated with an anti-,u chain serum (Dako Immunoglobulins a/s) by adding to each well 0-2 ml of a 1/500 dilution of the serum in 0-05 M carbonate/bicarbonate buffer pH 96. The plates were then kept at room temperature for 48 h and before use shaken dry and rinsed once with phosphate buffer saline (Dulbecco A) supplemented with 005% Tween 20 and 0-1 % bovine serum albumen (PBSTA).
TEST PROCEDURE Sera to be tested were diluted 1/100 in PBSTA and 02 ml aliquots added to duplicate anti-V treated wells of a micro-ELISA plate. The plate was held at 37°C for two hours. After washing with PBSTA five times, 0-2 ml of a 1/20 dilution of rubella antigen prepared in BHK 21 cells (Public Health Laboratory, Division of Microbiological Reagents and Quality Control) in PBSTA was added to each well and the plate was held at +4°C for 16-24 h. The plate was washed five times with PBSTA, after which 0-2 ml of the enzyme-conjugate diluted 1/500 in PBSTA was added to each well and incubated at 37°C for two hours. The washing was repeated and then 0-1 ml of the freshly prepared substrate (0 4 mg/ml 0-phenylenediamine and 0-2 mg/ml urea peroxide in 0075 M citrate phosphate buffer pH 5 0) was added to each well. Thirty-five sera were tested from 28 infants with congenital rubella. Figure 3 shows these results. All of the 29 sera taken before the seventh month of The application of this test for IgM antibody detection not only to rubella but also to many other infectious agents should greatly improve the scope of the diagnostic laboratory.
